Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
18 oct. 2021 17h45 HE
|
Lucid Diagnostics Inc.
NEW YORK, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq:...
Lucid Diagnostics Announces Pricing of Initial Public Offering
13 oct. 2021 22h15 HE
|
Lucid Diagnostics Inc.
NEW YORK, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq:...